GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise
These medications work through several mechanisms: Slowing gastric emptying (delaying how quickly food moves from your stomach to intestines) Increasing feelings of fullness and appetite suppression Helping regulate blood glucose levels Helping reduce food noise and fear of being hungry Popular GLP-1 weight loss medications include: Semaglutide (branded as Ozempic for diabetes, Wegovy for weight management) Tirzepatide (Mounjaro for diabetes, Zepbound for weight management) Liraglutide (Victoza for diabetes, Saxenda for weight management) Dulaglutide (Trulicity) Why Do GLP-1 Medications Cause Constipation
However, we found another nine clinical trials that are ongoing: six for alcohol, one for opiates and two for nicotine (Supplementary Section 3)
27.1% and 33.1% vs
Why Do We Feel Hungry Often
In contrast, in the liraglutide-treated group, the mean daily HR increased significantly from baseline at all times (66.5 10.2 to 79.7 10.5 bpm